Online Scheduling now available! Schedule Now.
Preimplantation genetic testing (PGT) of embryos is an option offered at Main Line Fertility that increases the possibility of a successful pregnancy after in vitro fertilization (IVF). PGT helps identify embryos that have genetic abnormalities that can result in a miscarriage or genetic disorder and allows patients to know the sex of the embryos if they wish.
To perform preimplantation genetic testing during the IVF process, embryologists remove a small sample of cells from the outer layer (called the trophectoderm) of a blastocyst on day 5, day 6, or day 7 of culture. The blastocyst is frozen after the sample is removed and remains at Main Line Fertility’s laboratory. The biopsy sample is sent to a separate laboratory for genetic testing.
Screens for aneuploidy which is too few or too many chromosomes. Aneuploidy can lead to IVF failure or miscarriage and occurs randomly in embryos during development.
Diagnoses specific genetic disorders in embryos such as Cystic Fibrosis, Fragile X, Muscular Dystrophy, BRCA, Thalassemia, Tay Sachs and others.
Identifies whether the embryo has a structural rearrangement of its chromosomal matter. PGT-SR can be performed to improve the chance of establishing a healthy pregnancy for people with a chromosomal translocation.
Couples and individuals who may benefit from PGT include:
The fertility specialists of Main Line Fertility are proud to offer a wide range of fertility care services in Pennsylvania to meet every patient’s need, including PGT and fertility treatments like IUI, IVF, egg and sperm donation, and more. Connect with Main Line Fertility today to schedule a consultation by filling out our online form or contact us directly at one of our fertility clinics in Philadelphia, Bryn Mawr, West Chester, Havertown, Reading, or Fort Washington, PA.
